- Home
- HALO vs MKTX Comparison
HALO vs MKTX Comparison
Compare HALO & MKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- MKTX
- Stock Information
- Founded
- HALO 1998
- MKTX 2000
- Country
- HALO United States
- MKTX United States
- Employees
- HALO N/A
- MKTX N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- MKTX Investment Bankers/Brokers/Service
- Sector
- HALO Health Care
- MKTX Finance
- Exchange
- HALO Nasdaq
- MKTX Nasdaq
- Market Cap
- HALO 7.4B
- MKTX 8.1B
- IPO Year
- HALO N/A
- MKTX 2004
- Fundamental
- Price
- HALO $49.48
- MKTX $214.72
- Analyst Decision
- HALO Buy
- MKTX Buy
- Analyst Count
- HALO 9
- MKTX 9
- Target Price
- HALO $63.78
- MKTX $241.78
- AVG Volume (30 Days)
- HALO 2.1M
- MKTX 493.0K
- Earning Date
- HALO 05-06-2025
- MKTX 05-07-2025
- Dividend Yield
- HALO N/A
- MKTX 1.39%
- EPS Growth
- HALO 55.40
- MKTX N/A
- EPS
- HALO 3.76
- MKTX 5.76
- Revenue
- HALO $1,084,306,000.00
- MKTX $815,355,000.00
- Revenue This Year
- HALO $20.06
- MKTX $7.50
- Revenue Next Year
- HALO $24.20
- MKTX $10.21
- P/E Ratio
- HALO $17.71
- MKTX $37.83
- Revenue Growth
- HALO 25.64
- MKTX 7.33
- 52 Week Low
- HALO $41.28
- MKTX $186.84
- 52 Week High
- HALO $70.51
- MKTX $296.68
- Technical
- Relative Strength Index (RSI)
- HALO 36.86
- MKTX 45.70
- Support Level
- HALO $58.38
- MKTX $216.95
- Resistance Level
- HALO $69.94
- MKTX $232.84
- Average True Range (ATR)
- HALO 3.06
- MKTX 5.92
- MACD
- HALO -0.11
- MKTX -0.78
- Stochastic Oscillator
- HALO 6.60
- MKTX 10.99
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About MKTX MarketAxess Holdings Inc.
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.